U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 2,146 records

Showing results for "factor".

  1. Data Points #18: Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/diabetes-medicare-use/research
    January 29, 2014 - It is a major risk factor for cardiovascular disease and the leading cause of kidney failure, nontraumatic

  2. Evaluation of the AHRQ Healthcare Horizon Scanning System | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/horizon-scan/research
    May 26, 2016 - was due to the absence of public information on this intervention until attainment of FDA approval—a factor

  3. Effective Health Care (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
    January 01, 2009 - Can FLC reliably be used as an independent risk factor for progression to MM in MGUS patients?

  4. Procalcitonin for Diagnosis and Management of Sepsis | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/procalcitonin/research-protocol
    April 26, 2011 - assessed based on an approach applied to a systematic review of testing for human epidermal growth factor … would be a trial in which randomized assignment to treatment groups would be stratified by a predictive factor … level or in which patients were randomized to receive treatment guided by a predictive factor or not … adequately powered stratified randomization would allow valid inferences of treatment by predictive factor … efficacy of two treatments, whereas single-arm studies can only assess the association between predictive factor

  5. VTE Surveillance Assessment_49_low_SPI (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
    December 01, 2012 - Classes include oral antiplatelet agents, injectable LMWHs, injectable UFH, injectable or oral factor … As such, it is likely inferior to factor Xa inhibitors in the balance of benefits and harms as well … UFH vs. factor Xa inhibitors vs. … A dose- ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous … UFH vs. factor Xa inhibitors vs.

  6. #06 Developmental Delays ADHD, and Autism (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Oxytocin factor - 30 ml nasal spray. [internet]. Amazon.com, Inc. … Available: http://www.amazon.com/Oxytocin- Factor-30-Nasal-Spray/dp/B007K8LTD2. 42. … Oxytocin factor. [internet]. ABC Nutriceuticals [accessed 2013 Nov 21]. [2 p]. … startswith=oxytocin&x=0&y=0 http://www.fda.gov/ http://www.amazon.com/Oxytocin-Factor-30-Nasal-Spray/ … dp/B007K8LTD2 http://www.amazon.com/Oxytocin-Factor-30-Nasal-Spray/dp/B007K8LTD2 http://tryoxytoday.com

  7. Rheumatoid-Arthritis-Medicine Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - leflunomide, methotrexate [MTX], and sulfasalazine), and biologic DMARDs (five anti-tumor necrosis factor … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Abbreviations ACR American College of Rheumatology Anti-TNF Anti-tumor necrosis factor drugs CDER Center

  8. Topic Suggestion Description | Effective Health Care Program

    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-asthmatic-and-asthma-prone-children-what-is-the-comparative-effectiveness-of-treating-with-allergen-specific-immunotherapy-plus-standard-vs-standard-alone
    September 03, 2009 - Could also stratify by environmental factor, socioeconomic status, ethnicity.

  9. Emerging Approaches to Diagnosis and Treatment of Non-Muscle-Invasive Bladder Cancer | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research-protocol
    July 21, 2014 - taking into account diagnostic testing, management, and long term follow up. 4 The most common risk factor … using techniques such as fluorescence in situ hybridization [FISH] assay or mRNA); fibroblast growth factor … cytokeratin fragments (e.g., CYFRA 21-1, TPA, TPS); survivin; telomerase; vascular endothelial growth factor … nuclear matrix protein or nmp22 or fluorescence in situ hybrid$ or (fish adj assay$) or fibroblast growth factor … cyfra 21-1 or (cytokerat$ adj3 (tpa or tps)) or survivin or telomeras$ or vascular endothelial growth factor

  10. Bladder-Cancer-Non-Muscle-Invasive Research-Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
    July 21, 2014 - taking into account diagnostic testing, management, and long term follow up.4 The most common risk factor … using techniques such as fluorescence in situ hybridization [FISH] assay or mRNA); fibroblast growth factor … cytokeratin fragments (e.g., CYFRA 21-1, TPA, TPS); survivin; telomerase; vascular endothelial growth factor … matrix protein or nmp22 or fluorescence in situ hybrid$ or (fish adj assay$) or fibroblast growth factor … cyfra 21-1 or (cytokerat$ adj3 (tpa or tps)) or survivin or telomeras$ or vascular endothelial growth factor

  11. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - Randomized Controlled Trial; SCEPC: Southern California Evidence-based Practice Center; TNF: Tumor Necrosis Factor … Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection … and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor … Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including … Randomized Controlled Trial; SCEPC: Southern California Evidence-based Practice Center; TNF: Tumor Necrosis Factor

  12. Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
    August 06, 2010 - injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … what is the relative impact of injectable antithrombotic agents (LMWH vs. unfractionated heparin vs. factor … Factor Xa Inhibitors Rivaroxiban (Xarelto®) Ortho-McNeil-Janssen Investigational drug, not yet … methods of thromboprophylaxis versus control or compare injectable antithrombotic agents (LMWH, UFH, factor

  13. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
    February 01, 2008 - injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … what is the relative impact of injectable antithrombotic agents (LMWH vs. unfractionated heparin vs. factor … Factor Xa Inhibitors Rivaroxiban (Xarelto®) Ortho-McNeil- Janssen Investigational drug, not … methods of thromboprophylaxis versus control or compare injectable antithrombotic agents (LMWH, UFH, factor

  14. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
    February 01, 2008 - injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … what is the relative impact of injectable antithrombotic agents (LMWH vs. unfractionated heparin vs. factor … Factor Xa Inhibitors Rivaroxiban (Xarelto®) Ortho-McNeil- Janssen Investigational drug, not … methods of thromboprophylaxis versus control or compare injectable antithrombotic agents (LMWH, UFH, factor

  15. Simulation-Based Comparison of Methods and Meta-Analysis of Proportions and Rates (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/metanalysis-proportion-rate-comparison_research.pdf
    November 01, 2013 - The correction factor is an analytic choice and not a simulation parameter; however it is listed here … , or correction factor for short. … Since for untransformed proportions, the correction factor is needed only in the variance estimate, … of the correction factor and the sample size of the study. … , and increases as the correction factor gets larger.

  16. Data Points #16: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008 | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/prostate-cancer-radiation/research
    November 30, 2012 - facilities.7 IMRT is increasingly used in the treatment of several tumors and has been identified as a major factor

  17. PULMONARY with "Discussions" in Exec Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
    October 01, 2015 - Esbriet®) is a synthetic pyridone analogue reported to inhibit the synthesis of transforming growth factor … receptors purportedly involved in the pathogenesis of IPF, including vascular endothelial growth factor … receptor 2 (VEGFR2), fibroblast growth factor receptor (FGFR), and platelet-derived growth factor … receptor kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), fibroblast growth … factor receptor (FGFR), and platelet-derived growth factor receptor (PDGFR).

  18. Body Weight | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/body-weight
    September 29, 2011 - Terbutaline Pump for the Prevention of Preterm Birth Systematic Review Archived September 29, 2011 Strategies To Prevent Weight Gain in Adults: Future Research Needs Systematic Review Archived August 14, 2013 Strategies To Prevent Weight Gain Among Adults Systematic Rev…

  19. PowerPoint Presentation (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-frameworks.ppt
    June 01, 2012 - screen-film mammography in breast cancer screening Project 2 (add-on test): Human epidermal growth factor … replacement for screening film mammography. - The add-on test example uses a human epidermal growth factor … Initial ambiguous claim: Amplification and protein expression assays of the human epidermal growth factor … It involves the use of a human epidermal growth factor receptor 2 (HER2) gene amplification assay after … a refined claim that patients with equivocal results for over expression of human epidermal growth factor

  20. PowerPoint Presentation (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-frameworks.ppt
    June 01, 2012 - screen-film mammography in breast cancer screening Project 2 (add-on test): Human epidermal growth factor … replacement for screening film mammography. - The add-on test example uses a human epidermal growth factor … Initial ambiguous claim: Amplification and protein expression assays of the human epidermal growth factor … It involves the use of a human epidermal growth factor receptor 2 (HER2) gene amplification assay after … a refined claim that patients with equivocal results for over expression of human epidermal growth factor
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites